CTCX Carmell Corporation

Subscribe to $CTCX

Carmell Corporation

Subscribe to $CTCX

$CTCX

Medical/Dental Instruments

Health Care

IPO Year: 2021

Exchange: NASDAQ

Recent Analyst Ratings for Carmell Corporation

Date	Price Target	Rating	Analyst

See more ratings

Carmell Corporation Leadership Updates

Live Leadership Updates

CARMELL CORP REBRANDS AS LONGEVITY HEALTH HOLDINGS TO HIGHLIGHT BUSINESS FOCUS & GROWTH STRATEGY
Pittsburgh, PA, March 10, 2025 (GLOBE NEWSWIRE) -- PITTSBURGH, Mar. 10, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (NASDAQ:CTCX, CTCXW)), a bio-aesthetics company (the "Company", "we", "our", or "us"), today announced a comprehensive corporate rebranding initiative aimed at better aligning the Company's market and investor facing image with its business focus and growth strategy. As part of the rebranding, the Company has changed its corporate name to "Longevity Health Holdings, Inc." and, at the open of trading on March 10, 2025, the Company's common stock and redeemable warrants will begin trading under the symbols "XAGE" and "XAGEW", respectively. The Company has also launc
3/10/25 8:30:00 AM ET
$CTCX
Medical/Dental Instruments
Health Care
Carmell Corporation Appoints New CEO Following Addition to the Russell Microcap Index
PITTSBURGH, July 29, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (NASDAQ:CTCX), a bio-aesthetics company focused on skin and hair health ("Company" or "Carmell"), today announced the appointment of Ms. Kendra Bracken-Ferguson as Chief Executive Officer effective July 30, 2024 with Mr. Rajiv Shukla continuing to serve as Executive Chairman of the Company. Kendra's appointment comes at a pivotal moment of growth for the Company. Since its business combination in July 2023, the Company has completed a pivot towards skincare, recruited a top-tier Scientific Advisory Board, developed and tested 12 skincare products aimed at retail and medspa use, scaled up in-house manufacturing and packagi
7/29/24 8:30:00 AM ET
$CTCX
Medical/Dental Instruments
Health Care
Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary
PITTSBURGH, March 20, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (NASDAQ:CTCX), a bio-aesthetics company focused on skin and hair health ("Carmell", the "Company", "we", "our", or "us"), today announced the execution of a definitive agreement to sell its wholly owned subsidiary, Axolotl Biologix ("AxoBio") to the initial sellers of AxoBio for 3,845,337 shares of Carmell common stock, 4,243 shares of Carmell preferred stock and notes payable to the initial sellers in the aggregate amount of $8 million. "The sale of AxoBio enables our exit from the tissue graft space thereby facilitating a sharper organizational focus on the launch of our skincare products beginning in March 2024 and co
3/20/24 4:39:36 PM ET
$CTCX
Medical/Dental Instruments
Health Care

Carmell Corporation Press Releases

Fastest customizable press release news feed in the world

CARMELL CORP REBRANDS AS LONGEVITY HEALTH HOLDINGS TO HIGHLIGHT BUSINESS FOCUS & GROWTH STRATEGY
Pittsburgh, PA, March 10, 2025 (GLOBE NEWSWIRE) -- PITTSBURGH, Mar. 10, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (NASDAQ:CTCX, CTCXW)), a bio-aesthetics company (the "Company", "we", "our", or "us"), today announced a comprehensive corporate rebranding initiative aimed at better aligning the Company's market and investor facing image with its business focus and growth strategy. As part of the rebranding, the Company has changed its corporate name to "Longevity Health Holdings, Inc." and, at the open of trading on March 10, 2025, the Company's common stock and redeemable warrants will begin trading under the symbols "XAGE" and "XAGEW", respectively. The Company has also launc
3/10/25 8:30:00 AM ET
$CTCX
Medical/Dental Instruments
Health Care
Carmell Announces Closing of Elevai Skincare Acquisition
PITTSBURGH, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (NASDAQ:CTCX), a bio-aesthetics company focused on skin and hair health ("Carmell", the "Company", "we", "our", or "us"), today announced the closing of the previously announced acquisition of the skin and hair care business of Elevai Skincare, Inc. ("Elevai"), a leader in physician dispensed exosome skin and hair care products, pursuant to a definitive purchase agreement with PMGC Holdings Inc. (formerly Elevai Labs Inc.) ("PMGC") and Elevai, its wholly owned subsidiary (the "Acquisition"). At the closing of the Acquisition (the "Closing"), the purchase consideration consisted of the following: Approximately $1.1 mill
1/16/25 8:00:28 AM ET
$CTCX
Medical/Dental Instruments
Health Care
Carmell Announces Closing of Previously Announced PIPE Investment from Existing and New Investors to Support Commercial Build-out
PITTSBURGH, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (NASDAQ:CTCX), a bio-aesthetics company focused on skin and hair health ("Carmell", the "Company", "we", "our", or "us"), today announced the closing of its previously announced private placement with new and existing investors pursuant to a securities purchase agreement, dated December 23, 2024, for the issuance and sale of 8,065,210 shares of its common stock and an equal number of five-year warrants both priced at $0.23 per share, in a private placement for aggregate gross proceeds of $1.85 million before deducting offering expenses and fees (the "Private Placement"). The Private Placement was priced at a slight premium t
1/3/25 8:00:03 AM ET
$CTCX
Medical/Dental Instruments
Health Care
Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products
PITTSBURGH, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (NASDAQ:CTCX), a bio-aesthetics company focused on skin and hair health ("Carmell", the "Company", "we", "our", or "us"), today announced that it entered into a definitive purchase agreement with PMGC Holdings Inc. (formerly Elevai Labs Inc.) and its wholly owned subsidiary, Elevai Skincare Inc. ("Elevai"), to acquire the assets related to its skincare and haircare business (the "Acquisition"). The purchase consideration for the Acquisition is as follows: Approximately $1.1 million in Carmell common stock at the closing of the Acquisition (the "Closing");Approximately $57,000 in cash upon the sale of specified inventory ex
1/2/25 8:00:23 AM ET
$CTCX
Medical/Dental Instruments
Health Care
Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out
PITTSBURGH, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (NASDAQ:CTCX), a bio-aesthetics company focused on skin and hair health ("Carmell", the "Company", "we", "our", or "us"), today announced that it entered into a securities purchase agreement with new and existing investors for the issuance and sale of 8,065,210 shares of its common stock and an equal number of five-year warrants, both priced at $0.23 per share, in a private placement for aggregate gross proceeds of $1.85 million before deducting offering expenses and fees (the "Private Placement"). The warrants, if exercised, will result in an additional $1.85 million in proceeds to Carmell. The Private Placement was priced
12/24/24 8:30:00 AM ET
$CTCX
Medical/Dental Instruments
Health Care
Blushington Announces National Advisory Board to Guide Franchise Expansion
Board of Industry Leaders to Steer Strategic Growth as Blushington Aims to Award 130 Franchises by 2028 Blushington, the express luxury beauty franchise concept dedicated to making A-List beauty services accessible to all customers, today announced the formation of a National Advisory Board. This board will provide strategic guidance and support the company's ambitious plan to award 130 franchises by 2028. "We are delighted to bring together some of the most accomplished business leaders in beauty, franchising, commercial real estate, product development, and human capital solutions to provide strategic guidance and help increase the value of our business," said Natasha Cornstein, CEO of
10/22/24 10:00:00 AM ET
$CTCX
Medical/Dental Instruments
Health Care
Carmell Corporation Launches Skincare Partnership With Ladies Playbook to Support and Celebrate NFL Sports Community
PITTSBURGH, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (NASDAQ:CTCX), a bio-aesthetics company focused on skin and hair health ("Company" or "Carmell"), today announced a strategic partnership with Ladies Playbook, an exclusive community dedicated to providing support, information, and the connections for an NFL family to thrive wherever their football career takes them. The NFL is the most valuable sports franchise in the world, with annual revenues approaching $20 billion from 32 teams, collectively worth approximately $160 billion, according to Statista. This partnership comes as the new NFL season kicks into full gear and as Carmell aims to accelerate the growth of it
9/5/24 8:30:00 AM ET
$CTCX
Medical/Dental Instruments
Health Care
Carmell Corporation Appoints New CEO Following Addition to the Russell Microcap Index
PITTSBURGH, July 29, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (NASDAQ:CTCX), a bio-aesthetics company focused on skin and hair health ("Company" or "Carmell"), today announced the appointment of Ms. Kendra Bracken-Ferguson as Chief Executive Officer effective July 30, 2024 with Mr. Rajiv Shukla continuing to serve as Executive Chairman of the Company. Kendra's appointment comes at a pivotal moment of growth for the Company. Since its business combination in July 2023, the Company has completed a pivot towards skincare, recruited a top-tier Scientific Advisory Board, developed and tested 12 skincare products aimed at retail and medspa use, scaled up in-house manufacturing and packagi
7/29/24 8:30:00 AM ET
$CTCX
Medical/Dental Instruments
Health Care
Carmell Announces Successful Closing of $3.0 Million Private Placement
PITTSBURGH, April 11, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (NASDAQ:CTCX), a bio-aesthetics company focused on skin and hair health ("Carmell", the "Company", "we", "our", or "us"), today announced the closing of its previously announced private placement with new and existing investors (the "Private Placement"). The Company received gross proceeds from the Private Placement of $3 million, excluding offering expenses. The Company issued and sold an aggregate amount of 1,331,452 shares of its common stock upon the closing of the Private Placement at a price of $2.88 per share for the Company's Chief Executive Officer (which was the closing sale price of the Company's common stock on
4/11/24 4:30:00 PM ET
$CTCX
Medical/Dental Instruments
Health Care
Carmell Announces $3.0 Million Private Placement
PITTSBURGH, April 04, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (NASDAQ:CTCX), a bio-aesthetics company focused on skin and hair health ("Carmell", the "Company", "we", "our", or "us"), today announced that it entered into a securities purchase agreement with new and existing investors for the issuance and sale of approximately 1,333,333 shares of its common stock in a private placement at a price of $2.25 per common share for aggregate gross proceeds of 3 million dollars before deducting offering expenses (the "Private Placement"). The Chief Executive Officer of the Company participated in the Private Placement at a price of $2.88 per common share, which was the closing sale price of
4/4/24 8:30:00 AM ET
$CTCX
Medical/Dental Instruments
Health Care

Carmell Corporation

Recent Analyst Ratings for Carmell Corporation

Carmell Corporation

Recent Analyst Ratings for Carmell Corporation

Carmell Corporation Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Upton Richard A bought $2,336 worth of shares (5,000 units at $0.47), increasing direct ownership by 50% to 15,000 units (SEC Form 4)

Director Frisch Scott M. bought $515 worth of shares (1,009 units at $0.51) (SEC Form 4)

Director Gregory Kathryn bought $643 worth of shares (1,260 units at $0.51) (SEC Form 4)

Director Sturgeon Patrick A bought $643 worth of shares (1,261 units at $0.51) (SEC Form 4)

Chief Financial Officer Cassaday Bryan J. bought $218 worth of shares (475 units at $0.46), increasing direct ownership by 13% to 4,250 units (SEC Form 4)

Director Spenlehauer Gilles bought $515 worth of shares (1,009 units at $0.51) (SEC Form 4)

Director Gregory Kathryn bought $62 worth of shares (109 units at $0.57) (SEC Form 4)

Director Frisch Scott M. bought $50 worth of shares (87 units at $0.57) (SEC Form 4)

Director Sturgeon Patrick A bought $62 worth of shares (109 units at $0.57) (SEC Form 4)

Director Spenlehauer Gilles bought $50 worth of shares (87 units at $0.57) (SEC Form 4)

Carmell Corporation Leadership Updates

Live Leadership Updates

CARMELL CORP REBRANDS AS LONGEVITY HEALTH HOLDINGS TO HIGHLIGHT BUSINESS FOCUS & GROWTH STRATEGY

Carmell Corporation Appoints New CEO Following Addition to the Russell Microcap Index

Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary

Carmell Corporation Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by Carmell Corporation

Amendment: SEC Form SC 13G/A filed by Carmell Corporation

SEC Form SC 13G/A filed by Carmell Corporation (Amendment)

Carmell Corporation Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

SEC Form 4 filed by Chief Executive Officer Bracken-Ferguson Kendra

SEC Form 4 filed by Director Gregory Kathryn

SEC Form 4 filed by Chief Financial Officer Cassaday Bryan J.

SEC Form 4 filed by Director Sturgeon Patrick A

SEC Form 4 filed by Director Upton Richard A

SEC Form 4 filed by Chairman and CEO Shukla Rajiv

SEC Form 4 filed by Director Spenlehauer Gilles

SEC Form 4 filed by Director Frisch Scott M.

Director Upton Richard A bought $2,336 worth of shares (5,000 units at $0.47), increasing direct ownership by 50% to 15,000 units (SEC Form 4)

Director Frisch Scott M. bought $515 worth of shares (1,009 units at $0.51) (SEC Form 4)

Carmell Corporation Press Releases

Fastest customizable press release news feed in the world

CARMELL CORP REBRANDS AS LONGEVITY HEALTH HOLDINGS TO HIGHLIGHT BUSINESS FOCUS & GROWTH STRATEGY

Carmell Announces Closing of Elevai Skincare Acquisition

Carmell Announces Closing of Previously Announced PIPE Investment from Existing and New Investors to Support Commercial Build-out

Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products

Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out

Blushington Announces National Advisory Board to Guide Franchise Expansion

Carmell Corporation Launches Skincare Partnership With Ladies Playbook to Support and Celebrate NFL Sports Community

Carmell Corporation Appoints New CEO Following Addition to the Russell Microcap Index

Carmell Announces Successful Closing of $3.0 Million Private Placement

Carmell Announces $3.0 Million Private Placement

Carmell Corporation SEC Filings

SEC Form 424B3 filed by Carmell Corporation

Carmell Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

SEC Form 424B3 filed by Carmell Corporation

Carmell Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits

SEC Form 424B3 filed by Carmell Corporation

Carmell Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

SEC Form 424B3 filed by Carmell Corporation

SEC Form EFFECT filed by Carmell Corporation

SEC Form DEF 14A filed by Carmell Corporation

SEC Form DEF 14A filed by Carmell Corporation